ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1670 • ACR Convergence 2021

    Increased Prevalence of Gastroesophageal Disease Among Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis

    Patompong Ungprasert1, Nipith Charoenngam2, Ben Ponvilawan3, Pitchaporn Yingchoncharoen3 and Jerapas Thongpiya4, 1Cleveland Clinic, Cleveland Heights, OH, 2Mount Auburn Hospital, Boston, MA, 3Mahidol University, Bangkok, Thailand, 4Mahdiol University, Bangkok, Thailand

    Background/Purpose: Recent experimental studies have suggested that systemic inflammatory response could lead to impairment of lower esophageal function, resulting in gastroesophageal reflux disease (GERD). Epidemiologic…
  • Abstract Number: 0116 • ACR Convergence 2021

    COVID-19 mRNA Vaccine Side Effects Among Individuals with Rheumatic Disease

    Kaleb Michaud1, Adam Cornish2, Alison Freifeld1, Patricia Katz3 and Kristin Wipfler2, 1University of Nebraska Medical Center, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 3University of California San Francisco, San Francisco, CA

    Background/Purpose: Over 135 million Americans were fully vaccinated to COVID-19 by June 2021, yet there was a paucity of data on side effects for those…
  • Abstract Number: 0479 • ACR Convergence 2021

    A Novel Semi-automated Classifier of Radiographic Hip Osteoarthritis on DXA Scans Is Strongly Predictive of Pain, Clinical Diagnosis and Joint Replacement: Findings from 40,000 Participants in UK Biobank

    Benjamin Faber1, Raja Ebsim2, Fiona Saunders3, Monika Frysz1, Claudia Lindner2, Jennifer Gregory3, Richard Aspden3, Nicholas Harvey4, George Davey Smith1, Timothy Cootes2 and Jon Tobias1, 1University of Bristol, Bristol, United Kingdom, 2University of Manchester, Manchester, United Kingdom, 3University of Aberdeen, Aberdeen, United Kingdom, 4University of Southampton, Southampton, United Kingdom

    Background/Purpose: Radiographic hip osteoarthritis (rHOA) is traditionally defined on hip or pelvic radiographs, using subjective methods such as Kellgren-Lawrence scoring. Associations between subjective rHOA measures…
  • Abstract Number: 0588 • ACR Convergence 2021

    Effectiveness of TNFi versus Non-TNFi Biologics on Disease Activity in Obese Patients with Rheumatoid Arthritis: Data from the ACR’s RISE Registry

    Milena Gianfrancesco1, Jing Li1, Clairissa Ja2, Andrea Seet1, Gabriela Schmajuk1 and Jinoos Yazdany1, 1University of California San Francisco, San Francisco, CA, 2UC Davis, San Francisco

    Background/Purpose: Our understanding of how medications such as biologic disease modifying anti-rheumatic drugs and targeted small molecules (b/tsDMARDs) influence disease activity in RA is based…
  • Abstract Number: 0976 • ACR Convergence 2021

    Cumulative Social Disadvantage Predicts an Arthritis Diagnosis: A Cross-sectional Analysis of the National Survey of Children’s Health (NSCH)

    William Soulsby, Erica Lawson and Matthew Pantell, University of California San Francisco, San Francisco, CA

    Background/Purpose: The impact of social determinants of health in juvenile idiopathic arthritis (JIA) remains poorly understood. Racial disparities exist in JIA, including increased pain and…
  • Abstract Number: 1121 • ACR Convergence 2021

    Association of Healthcare Costs and Utilization with Increasing Severity of Pain in Osteoarthritis Patients: An 18-Year Retrospective Study

    Jove Graham1, Tonia Novosat1, Haiyan Sun1, Brian Piper1, Joseph Boscarino1, Melissa Kern1, Vanessa Duboski1, Eric Wright1, Craig Beck2, Rebecca Robinson3, Edward Casey4, Jerry A. Hall3 and Patricia Schepman4, 1Geisinger, Danville, PA, 2Pfizer, Inc., London, 3Eli Lilly and Company, Indianapolis, IN, 4Pfizer, Inc., New York, NY

    Background/Purpose: Osteoarthritis (OA) is a disease with complex pathogenesis, and it is important to understand a patient's level of severity in order to plan and…
  • Abstract Number: 1712 • ACR Convergence 2021

    Adverse Outcomes and Rehospitalization After Delivery Among Women with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Their Infants

    Julianna Sabo1, Namrata Singh2, Deborah Crane1, David Doody3, Melissa Schiff4 and Beth Mueller5, 1University of Washington, Seattle, WA, 2University of Washington, Bellevue, WA, 3Fred Hutchinson Cancer Research Center, Seattle, WA, 4University of Washington, University of New Mexico, Seattle, WA, 5Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA

    Background/Purpose: Women with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) have greater risk of adverse obstetric and birth outcomes than women without these conditions.…
  • Abstract Number: 0132 • ACR Convergence 2021

    Hospitalization Rates Among Patients with Systemic Lupus Erythematosus: A Population Based Study

    Jesse Dabit1, Mehmet Hocaoglu2, Maria Valenzuela-Almada3, Shirley-Ann Osei-Onomah1, Sebastian Vallejo-Ramos1, Rachel Giblon1, Kurt Greenlund4, Kamil Barbour4, Cynthia Crowson5 and Ali Duarte-Garcia1, 1Mayo Clinic, Rochester, MN, 2University of Maryland Medical Center, Midtown Campus, Baltimore, MD, 3Division of Rheumatology, Mayo Clinic, Rochester, MN, 4Centers for Disease Control, Atlanta, GA, 5Mayo Clinic, Eyota, MN

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune multiorgan disease associated with significant morbidity and mortality. Although the survival rate for SLE patients has…
  • Abstract Number: 0480 • ACR Convergence 2021

    Signs of Regression to the Mean in Observational Data from a Nation-Wide Exercise and Education Intervention for Osteoarthritis

    Martin Englund1, Dorte Grønne2, Ewa Roos2, Søren Skou2 and Aleksandra Turkiewicz1, 1Lund University, Lund, Sweden, 2University of Southern Denmark, Odense, Denmark

    Background/Purpose: Patients who enroll in interventions are likely to do so when they experience a flare-up in symptoms. This may create issues in interpretation of…
  • Abstract Number: 0589 • ACR Convergence 2021

    Circulating Adipokines and Risk of Rheumatoid Arthritis in Women

    Zhe Fang1, Jing Cui2, Jeffrey Sparks1, Susan Malspeis2, Kazuki Yoshida1, Karen Costenbader3, Elizabeth Karlson1 and Bing Lu4, 1Brigham and Women's Hospital, Boston, MA, 2Brigham Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Belmont, MA, 4Brigham and Women's Hospital and Harvard Medical School, Newton, MA

    Background/Purpose: Adipokines secreted by adipose tissues thought to be involved in RA pathogenesis by stimulating systematic inflammation. We examined the association between circulating adipokines (leptin,…
  • Abstract Number: 0989 • ACR Convergence 2021

    Risk Factors for Hydroxychloroquine Retinopathy and Its Subtypes – Prospective Adjudication Analysis of 4,899 Incident Users

    April Jorge1, Ronald Melles2, Carol Conell3, Na Lu4, Michael Marmor5, Lucy Young6, Natalie McCormick1, Yuqing Zhang7 and Hyon K. Choi8, 1Massachusetts General Hospital, Boston, MA, 2Redwood City Medical Center, Department of Ophthalmology, Kaiser Permanente Northern California, Redwood City, CA, 3Kaiser Permanente Northern California, Palo Alto, CA, 4Arthritis Research Canada, Vancouver, BC, Canada, 5Stanford University, Palo Alto, CA, 6Massachusetts Eye and Ear Institute, Harvard Medical School, Boston, MA, 7Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Harvard Medical School, Boston, MA, 8Massachusetts General Hospital, Lexington, MA

    Background/Purpose: Hydroxychloroquine (HCQ) is a key treatment for patients with lupus and other rheumatic diseases; however, the known risk factors for HCQ retinopathy (its major…
  • Abstract Number: 1134 • ACR Convergence 2021

    Osteoarthritis Risk Is Increased in Patients with Atopic Disease

    Matthew Baker1, Khushboo Sheth2, Rong Lu3, Di Lu3, Ericka von Kaeppler4, Archana Bhat4, David Felson5 and William Robinson4, 1Stanford University, Menlo Park, CA, 2Stanford University/VA Palo Alto, Atherton, CA, 3Stanford University, Stanford, 4Stanford University, Palo Alto, CA, 5Boston University, Boston, MA

    Background/Purpose: Osteoarthritis (OA) is a highly prevalent disease resulting in joint pain and impaired function. Allergic pathways, including mast cell activation, may play a key…
  • Abstract Number: 1730 • ACR Convergence 2021

    Disease Activity and Outcome in Pregnancies of Patients with SpA – Data from the German Pregnancy Register RHEKISS

    Anja Weiß1, Christina Bungartz1, Jutta Richter2, Susanna Späthling-Mestekemper3, Xenofon Baraliakos4, Peer Aries5, Rebecca Fischer-Betz6 and Anja Strangfeld7, 1DRFZ, Berlin, Germany, 2Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, 3Rheumapraxis München, München, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 5Rheumatologie in Hamburg, Hamburg, Germany, 6Uniklinik Dsseldorf, Dsseldorf, Germany, 7Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany

    Background/Purpose: SpA is a severe chronic inflammatory disease, which affects quality of life and functional status. It frequently occurs in women of childbearing age. Active…
  • Abstract Number: 0257 • ACR Convergence 2021

    Can We Assess Disability in Juvenile Idiopathic Arthritis with Two Simple Questions? Results from the CAPRI Registry

    Meghan McPherson1, Kristin Houghton2, Nikola Surjanovic3, Thomas Loughin3, Roberta Berard4, Jean-Philippe Proulx-Gauthier5, Gaelle Chedeville6, Dax Rumsey7, Heinrike Schmeling8, Nadia Luca8, Nicole Johnson8, Tommy Gerschman2, Paivi Miettunen8, Evelyn Rozenblyum9, Herman Tam10, Lilliam Lim7, Kimberly Morishita2, Rosie Scuccimarri11, Johannes Roth12, Ciaran Duffy12, Lori Tucker13, Brian Feldman14 and Jaime Guzman15, 1University of Manitoba, Winnipeg, MB, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Simon Fraser University, Burnaby, BC, Canada, 4London Health Sciences Centre, London, ON, Canada, 5Laval University, Québec City, QC, Canada, 6The Montreal Children's Hospital, Montréal, QC, Canada, 7University of Alberta, Edmonton, AB, Canada, 8University of Calgary, Calgary, AB, Canada, 9Temerty School of Medicine and Unity Health, Toronto, ON, Canada, 10Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada, 11MgGill University, Montréal, QC, Canada, 12University of Ottawa, Ottawa, ON, Canada, 13BC Children's Hospital, Vancouver, BC, Canada, 14The Hospital for Sick Children, Toronto, ON, Canada, 15University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: To assess if a combination of two questions (Functional Arthritis Screening with Two Questions - FAST index) can detect and roughly estimate the degree…
  • Abstract Number: 0482 • ACR Convergence 2021

    Metformin Use Reduces the Risk of Developing Osteoarthritis: A Propensity Score Matching Study

    Khushboo Sheth1, Di Lu2, Rong Lu2, William Robinson3 and Matthew Baker4, 1Stanford University/VA Palo Alto, Atherton, CA, 2Stanford University, Stanford, 3Stanford University, Palo Alto, CA, 4Stanford University, Menlo Park, CA

    Background/Purpose: Preclinical and observational data suggest a protective effect of metformin against developing osteoarthritis (OA).1,2 In this retrospective cohort study, we evaluated the time to…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology